Colgate-Palmolive Company vs Nuwellis Inc — how do they compare? Colgate-Palmolive Company trades at $90.95 (market cap $74.59B), while Nuwellis Inc trades at $3.16 (market cap $1.02M). The key difference: Colgate-Palmolive Company is far larger — about 73127.5× Nuwellis Inc's market cap, and Colgate-Palmolive Company pays a 2.27% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| CL | NUWE | |
|---|---|---|
Market Cap | $74.59B | $1.02M |
Sector | Consumer Staples | Technology |
52-Week High | $99.14 | $558.26 |
52-Week Low | $74.98 | $2.80 |
Enterprise Value | $81.22B | -$789.97K |
Dividend Yield | 2.27% | — |
Signals from Pluang's Aura AI — not financial advice
Colgate-Palmolive (CL) trades at $93.21, up 1.05% with a bullish technical signal and consistent earnings beats. The stock shows strong profitability with 60.06% gross margins and 822.05% ROE, though valuation metrics appear elevated with a P/E of 36.13. Recent dividend declarations and positive analyst coverage (42% buy rating) support the defensive stock's appeal amid market rotation into stable cash flow names.
Outlook remains positive with a $97 consensus price target representing 4% upside, though premium valuation and North American segment softness present headwinds. The company's 64-year dividend growth streak and global diversification provide stability, while inflation pressures and competitive threats require monitoring for sustained outperformance.
No Aura AI signal available yet.
Trailing returns across standard periods
Since its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product company. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries (international sales account for about 70% of its consolidated total, including approximately 45% from emerging regions). It also owns specialty pet food maker Hill's, which sells its products through veterinarians and specialty pet retailers.
Read more on CL →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →